Directors share purchase
20 Novembro 2007 - 6:46AM
UK Regulatory
RNS Number:0691I
Arana Therapeutics Limited
20 November 2007
For Immediate Release 20 November 2007
ARANA THERAPEUTICS LTD
DIRECTOR'S SHARE PURCHASE
Arana Therapeutics Ltd, (LSE: AAHx ASX: AAH) ("Arana" or the "Company"), the
Australian biopharmaceutical company, formed through the merger of Peptech and
EvoGenix in August 2007. The Company uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer. The Company has received notification on 16 November 2007
that the following Director purchased ordinary fully paid shares in the capital
of the Company. Details are as follows:
Director Direct or No. of Date Price per Total Subsequent
Indirect Ordinary Purchased Share (A$) Consideration beneficial
Interest Shares (A$) holding
purchased
Greg Direct 50,000 15 1.185 59,250 300,000
Bundy November
2007
For further information, please contact:
Arana Therapeutics Ltd
Dr John Chiplin, Chief Executive Officer +61 (0)2 9870 8788
Niall Henderson, Chief Financial Officer +61 (0)2 9870 8788
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com) +44 (0)20 7466 5000
Rebecca Skye Dietrich / Catherine Breen
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSOKKKQFBDKNDB
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Arana Therap. da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Arana Therapeutics